Bellwether Bio, Inc. — Form D/A
Bellwether Bio, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2017-04-06. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-06
- Form: D/A
- Accession: 0001674220-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.8M
- Investors: 20
- Date of first sale: 2016-05-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-263609
Issuer
- Name: Bellwether Bio, Inc.
- CIK: 0001674220
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2015
- Address: 600 1st Avenue, SEATTLE, WA, 98104
- Phone: 2069995373
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Rahul Shendure | Director | Seattle, WA |
| Rahul Shendure | Executive Officer | Seattle, WA |
| Rahul Shendure | Promoter | Seattle, WA |
| Matthew Snyder | Director | ARMONK, NY |
| Matthew Snyder | Executive Officer | ARMONK, NY |
| Matthew Snyder | Promoter | ARMONK, NY |
Other filings by this issuer (2)
More